Clinical trial
Phase I/II Trial of Infusional Gemcitabine in Combination With Carboplatin in…
NCT00212043 · National University Hospital, Singapore, Other · Completed
Key facts
| NCT number | NCT00212043 |
|---|---|
| Title | Phase I/II Trial of Infusional Gemcitabine in Combination With Carboplatin in Chemonaive Non-small Cell Carcinoma |
| Official title | Phase I/II Trial of Infusional Gemcitabine in Combination With Carboplatin in Chemonaive Non-small Cell Carcinoma |
| Lead sponsor | National University Hospital, Singapore, Other |
| Collaborators | Eli Lilly and Company Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Non Small Cell Lung Cancer |
| Intervention type | Drug |
| Interventions | carboplatin and gemcitabine |
| Enrollment | 74 |
| Start date | Jul 1, 2000 |
| Completion | Feb 1, 2004 |
| First posted | Sep 21, 2005 |
| Last update posted | Oct 8, 2009 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: